Robert Sherville-Payne

Company Secretary

With a professional legal and compliance background and over 25 years of commercial experience, Robert brings significant expertise as a solicitor to his role as General Counsel and Company Secretary at Medicines Discovery Catapult.

Having trained and worked at law firm Hogan Lovells in London, Robert spent 14 years at AstraZeneca in a range of legal roles focused on all aspects of drug discovery, development, operations and legal risk management. Robert subsequently moved on to leadership legal and compliance roles at BUPA, BAE Systems and other corporate and SME organisations, before joining MDC as General Counsel and Company Secretary in May 2022.

Having created and led legal and business focussed teams within life science and broader industrial sectors, Robert has driven improved governance and decision-making practices. Robert brings detailed experience of legal risk, corporate governance and risk management , combined with an understanding of the critical need to harness these tools to enhance financial performance, business development and commercial opportunity.

With responsibility for the Legal function, Board liaison, the Office of the CEO, risk management, Intellectual Property and oversight for MDC’s approach to ESG (Environmental, Social and Governance), Robert is centrally placed to support MDC’s mission of reshaping drug discovery for patient benefit.